Petros Family Wealth LLC Acquires Shares of 2,071 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Petros Family Wealth LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,071 shares of the medical equipment provider’s stock, valued at approximately $1,081,000. Intuitive Surgical accounts for 1.2% of Petros Family Wealth LLC’s investment portfolio, making the stock its 21st largest position.

Several other large investors also recently modified their holdings of the business. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the period. Geode Capital Management LLC boosted its stake in shares of Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares in the last quarter. Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after buying an additional 86,488 shares during the period. Norges Bank bought a new position in Intuitive Surgical in the fourth quarter worth about $2,401,493,000. Finally, Invesco Ltd. raised its stake in Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock worth $2,165,184,000 after buying an additional 295,025 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have weighed in on ISRG shares. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Bernstein Bank increased their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Leerink Partners raised their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Evercore ISI upped their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $493.60 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a fifty day moving average price of $532.72 and a 200-day moving average price of $532.36. The stock has a market capitalization of $175.81 billion, a P/E ratio of 77.00, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.